About this Journal Submit a Manuscript Table of Contents

Citations to this Journal [3,881 citations: 1,201–1,300 of 3,114 articles]

Articles published in PPAR Research have been cited 3,881 times. The following is a list of the 3,114 articles that have cited the articles published in PPAR Research.

  • Paola Ballesteros-Zebadua, Miguel Angel Celis, Carlos Paz, Javier Franco-Perez, and Anahi Chavarria, “Radiation-Induced Neuroinflammation and Radiation Somnolence Syndrome,” Cns & Neurological Disorders-Drug Targets, vol. 11, no. 7, pp. 937–949, 2012. View at Publisher · View at Google Scholar
  • Der-Rong Din, and Jhong-Yan Jiang, “Delay-constrained survivable multicast routing problem in WDM networks,” Computer Communications, vol. 35, no. 10, pp. 1172–1184, 2012. View at Publisher · View at Google Scholar
  • Ishwarlal Jialal, and Harmeet Kaur, “The Role of Toll-Like Receptors in Diabetes-Induced Inflammation: Implications for Vascular Complications,” Current Diabetes Reports, vol. 12, no. 2, pp. 172–179, 2012. View at Publisher · View at Google Scholar
  • Katsutoshi Yoshizato, Chise Tateno, and Rie Utoh, “Mice with liver composed of human hepatocytes as an animal model for drug testing,” Current Drug Discovery Technologies, vol. 9, no. 1, pp. 63–76, 2012. View at Publisher · View at Google Scholar
  • Janardan K. Reddy, and Aurore Vluggens, “Nuclear Receptors and Transcription Factors in the Development of Fatty Liver Disease,” Current Drug Metabolism, vol. 13, no. 10, pp. 1422–1435, 2012. View at Publisher · View at Google Scholar
  • Julie Chamouton, and Norbert Latruffe, “PPAR alpha/HNF4 alpha Interplay on Diversified Responsive Elements. Relevance in the Regulation of Liver Peroxisomal Fatty Acid Catabolism,” Current Drug Metabolism, vol. 13, no. 10, pp. 1436–1453, 2012. View at Publisher · View at Google Scholar
  • Hammam I. El Hajj, Sailesh Surapureddi, Pierre Andreoletti, Joseph Vamecq, and Mustapha Cherkaoui-Malki, “Hepatic Steatosis and Peroxisomal Fatty Acid Beta-oxidation,” Current Drug Metabolism, vol. 13, no. 10, pp. 1412–1421, 2012. View at Publisher · View at Google Scholar
  • Joseph Vamecq, Gilbert Briand, Mustapha Cherkaoui-Malki, Pierre Andreolotti, Monique Fontaine, Nicole Porchet, Norbert Latruffe, and Anne-Frederique Dessein, “Mitochondrial Dysfunction and Lipid Homeostasis,” Current Drug Metabolism, vol. 13, no. 10, pp. 1388–1400, 2012. View at Publisher · View at Google Scholar
  • Fukasawa, Fujigaki, Yamamoto, Hishida, and Kitagawa, “Protein degradation by the ubiquitin-proteasome pathway and organ fibrosis,” Current Medicinal Chemistry, vol. 19, no. 6, pp. 893–900, 2012. View at Publisher · View at Google Scholar
  • Almonacid-Urrego, Sánchez-Campos, Tuñón, and González-Gallego, “Non-alcoholic steatohepatitis: What can we learn from animal models?,” Current Medicinal Chemistry, vol. 19, no. 9, pp. 1389–1404, 2012. View at Publisher · View at Google Scholar
  • Szalárdy, Klivényi, Zádori, Fülöp, Toldi, and Vécsei, “Mitochondrial disturbances, tryptophan metabolites and neurodegeneration: Medicinal chemistry aspects,” Current Medicinal Chemistry, vol. 19, no. 13, pp. 1899–1920, 2012. View at Publisher · View at Google Scholar
  • M. T. Batista, G. Costa, M. C. Lopes, M. T. Cruz, and V. Francisco, “Intracellular Signaling Pathways Modulated by Phenolic Compounds: Application for New Anti-Inflammatory Drugs Discovery,” Current Medicinal Chemistry, vol. 19, no. 18, pp. 2876–2900, 2012. View at Publisher · View at Google Scholar
  • L. Steardo, C. Marasco, M. R. Carratu, A. Signorile, and C. Scuderi, “Are Retinoids a Promise for Alzheimer's Disease Management?,” Current Medicinal Chemistry, vol. 19, no. 36, pp. 6119–6125, 2012. View at Publisher · View at Google Scholar
  • Baoming Nie, Haixia Wang, Timothy Laurent, and Sheng Ding, “Cellular reprogramming: a small molecule perspective,” Current Opinion in Cell Biology, vol. 24, no. 6, pp. 784–792, 2012. View at Publisher · View at Google Scholar
  • Tommy Pacana, and Arun J. Sanyal, “Vitamin e and nonalcoholic fatty liver disease,” Current Opinion in Clinical Nutrition and Metabolic Care, vol. 15, no. 6, pp. 641–648, 2012. View at Publisher · View at Google Scholar
  • Philip F. Stahel, Todd VanderHeiden, and Michael A. Finn, “Management strategies for acute spinal cord injury,” Current Opinion in Critical Care, vol. 18, no. 6, pp. 651–660, 2012. View at Publisher · View at Google Scholar
  • Sarah F. Bortvedt, and P. Kay Lund, “Insulin-like growth factor 1,” Current Opinion in Gastroenterology, vol. 28, no. 2, pp. 89–98, 2012. View at Publisher · View at Google Scholar
  • Jichun Yang, Yunfeng Zhou, and Youfei Guan, “PPARγ as a therapeutic target in diabetic nephropathy and other renal diseases,” Current Opinion in Nephrology and Hypertension, vol. 21, no. 1, pp. 97–105, 2012. View at Publisher · View at Google Scholar
  • Thomas Grewal, Basil D. Roufogalis, Moon Sun Kim, and Sidney Kung, “Methodologies for Investigating Natural Medicines for the Treatment of Nonalcoholic Fatty Liver Disease (NAFLD),” Current Pharmaceutical Biotechnology, vol. 13, no. 2, pp. 278–291, 2012. View at Publisher · View at Google Scholar
  • Xianhua Huang, Hao Huang, Walter Luyten, Longhuo Wu, Ruian Xu, and Linfu Li, “Insights on Biology and Pathology of HIF-1 alpha/-2 alpha, TGF beta/BMP, Wnt/beta-Catenin, and NF-kappa B Pathways in Osteoarthritis,” Current Pharmaceutical Design, vol. 18, no. 22, pp. 3293–3312, 2012. View at Publisher · View at Google Scholar
  • Kayo Masuko, “Contribution of dietary factors to peroxisome proliferator-activated receptor-mediated inflammatory signaling in arthritic diseases,” Current Rheumatology Reviews, vol. 8, no. 2, pp. 134–140, 2012. View at Publisher · View at Google Scholar
  • Philippe Lefebvre, Michal Pawlak, and Bart Staels, “General Molecular Biology and Architecture of Nuclear Receptors,” Current Topics In Medicinal Chemistry, vol. 12, no. 6, pp. 486–504, 2012. View at Publisher · View at Google Scholar
  • Angela Zampella, Maria Valeria D'Auria, and Valentina Sepe, “Natural Ligands for Nuclear Receptors: Biology and Potential Therapeutic Applications,” Current Topics In Medicinal Chemistry, vol. 12, no. 6, pp. 637–669, 2012. View at Publisher · View at Google Scholar
  • María P. Menéndez-Gutiérrez, Tamás Roszer, and Mercedes Ricote, “Biology and therapeutic applications of peroxisome proliferator-activated receptors,” Current Topics in Medicinal Chemistry, vol. 12, no. 6, pp. 548–584, 2012. View at Publisher · View at Google Scholar
  • Cynthia J.M. Kane, Kevin D. Phelan, and Paul D. Drew, “Neuroimmune mechanisms in fetal alcohol spectrum disorder,” Developmental Neurobiology, vol. 72, no. 10, pp. 1302–1316, 2012. View at Publisher · View at Google Scholar
  • Antonio Cittadini, Raffaele Napoli, Maria Gaia Monti, Domenica Rea, Salvatore Longobardi, Paolo Antonio Netti, Marion Walser, Mariateresa Sama, Gianluca Aimaretti, Jorgen Isgaard, and Luigi Sacca, “Metformin Prevents the Development of Chronic Heart Failure in the SHHF Rat Model,” Diabetes, vol. 61, no. 4, pp. 944–953, 2012. View at Publisher · View at Google Scholar
  • Tong Lu, Qiang Chai, Ling Yu, Livius V. d'Uscio, Zvonimir S. Katusic, Tongrong He, and Hon-Chi Lee, “Reactive Oxygen Species Signaling Facilitates FOXO-3a/FBXO-Dependent Vascular BK Channel beta 1 Subunit Degradation in Diabetic Mice,” Diabetes, vol. 61, no. 7, pp. 1860–1868, 2012. View at Publisher · View at Google Scholar
  • I.N. Colmers, S.L. Bowker, and J.A. Johnson, “Thiazolidinedione use and cancer incidence in type 2 diabetes: A systematic review and meta-analysis,” Diabetes & Metabolism, vol. 38, no. 6, pp. 475–484, 2012. View at Publisher · View at Google Scholar
  • Kyung Soo Kim, Soo Kyung Kim, Kyung Mi Sung, Yong Wook Cho, and Seok Won Park, “Management of Type 2 Diabetes Mellitus in Older Adults,” Diabetes & Metabolism Journal, vol. 36, no. 5, pp. 336, 2012. View at Publisher · View at Google Scholar
  • Stephen J. Nicholls, and Kiyoko Uno, “Peroxisome proliferator-activated receptor (PPAR alpha/gamma) agonists as a potential target to reduce cardiovascular risk in diabetes,” Diabetes & Vascular Disease Research, vol. 9, no. 2, pp. 89–94, 2012. View at Publisher · View at Google Scholar
  • Somlak Chuengsamarn, Suthee Rattanamongkolgul, Rataya Luechapudiporn, Chada Phisalaphong, and Siwanon Jirawatnotai, “Curcumin Extract for Prevention of Type 2 Diabetes,” Diabetes Care, vol. 35, no. 11, pp. 2121–2127, 2012. View at Publisher · View at Google Scholar
  • Xilin Yang, Wing-Yee So, Ronald C.W. Ma, Linda W.L. Yu, Alice P.S. Kong, Heung Man Lee, Gang Xu, Risa Ozaki, Gary T.C. Ko, and Juliana C.N. Chan, “Use of thiazolidinedione and cancer risk in Type 2 diabetes: The Hong Kong diabetes registry,” Diabetes Research and Clinical Practice, vol. 97, no. 1, pp. e13–e17, 2012. View at Publisher · View at Google Scholar
  • Janice S.K. Ho, Soren Germer, Claudia H.T. Tam, Wing-Yee So, Mitchell Martin, Ronald C.W. Ma, Juliana C.N. Chan, and Maggie C.Y. Ng, “Association of the PPARG Pro12Ala polymorphism with type 2 diabetes and incident coronary heart disease in a Hong Kong Chinese population,” Diabetes Research and Clinical Practice, vol. 97, no. 3, pp. 483–491, 2012. View at Publisher · View at Google Scholar
  • Philip Home, “Cardiovascular Disease and Oral Agent Glucose-Lowering Therapies in the Management of Type 2 Diabetes,” Diabetes Technology & Therapeutics, vol. 14, no. S1, pp. S-33–S-42, 2012. View at Publisher · View at Google Scholar
  • A. Bénardeau, P. Verry, E.-A. Atzpodien, J. M. Funk, M. Meyer, J. Mizrahi, M. Winter, M. B. Wright, S. Uhles, and E. Sebokova, “Effects of the dual PPAR-α/γ agonist aleglitazar on glycaemic control and organ protection in the Zucker diabetic fatty rat,” Diabetes, Obesity and Metabolism, vol. 15, no. 2, pp. 164–174, 2012. View at Publisher · View at Google Scholar
  • J. P. H. Wilding, “PPAR agonists for the treatment of cardiovascular disease in patients with diabetes,” Diabetes, Obesity and Metabolism, vol. 14, no. 11, pp. 973–982, 2012. View at Publisher · View at Google Scholar
  • Ali Ghoochani, Khadijeh Shabani, Maryam Peymani, Kamran Ghaedi, Fereshteh Karamali, Khadijeh Karbalaei, Somayeh Tanhaie, Ahmad Salamian, Abolghasem Esmaeili, Sadegh Valian-Borujeni, Mehrdad Hashemi, Mohammad Hossein Nasr-Esfahani, and Hossein Baharvand, “The influence of peroxisome proliferator-activated receptor γ1 during differentiation of mouse embryonic stem cells to neural cells,” Differentiation, vol. 83, no. 1, pp. 60–67, 2012. View at Publisher · View at Google Scholar
  • Sarah L. Prior, Amy R. Clark, Danielle A. Jones, Steve C. Bain, Steve J. Hurel, Steve E. Humphries, and Jeffrey W. Stephens, “Association of the PGC-1 alpha rs8192678 variant with microalbuminuria in subjects with type 2 diabetes mellitus,” Disease Markers, vol. 32, no. 6, pp. 363–369, 2012. View at Publisher · View at Google Scholar
  • Cristina Martínez-García, Matej Orešič, Antonio Vidal-Puig, Gema Medina-Gomez, Adriana Izquierdo, Vidya Velagapudi, Yurena Vivas, Ismael Velasco, Mark Campbell, Keith Burling, Fernando Cava, and Manuel Ros, “Accelerated renal disease is associated with the development of metabolic syndrome in a glucolipotoxic mouse model,” DMM Disease Models and Mechanisms, vol. 5, no. 5, pp. 636–648, 2012. View at Publisher · View at Google Scholar
  • Hulya Yilmaz-Aydogan, Ozlem Kucukhuseyin, Ozlem Kurnaz, Basak Akadam-Teker, Ozlem Kurt, Atike Tekeli, Oguz Ozturk, and Turgay Isbir, “ Investigation of Polymorphic Variants of PPARD and APOE Genes in Turkish Coronary Heart Disease Patients ,” DNA and Cell Biology, vol. 31, no. 5, pp. 867–875, 2012. View at Publisher · View at Google Scholar
  • Peter A. McCullough, and Sajid Ali, “Cardiac and renal function in patients with type 2 diabetes who have chronic kidney disease: potential effects of bardoxolone methyl,” Drug Design Development And Therapy, vol. 6, pp. 141–149, 2012. View at Publisher · View at Google Scholar
  • Peter A McCullough, and Sajid Ali, “Cardiac and renal function in patients with type 2 diabetes who have chronic kidney disease: Potential effects of bardoxolone methyl,” Drug Design, Development and Therapy, vol. 6, pp. 141–149, 2012. View at Publisher · View at Google Scholar
  • Alvaro Cerda, Mario Hiroyuki Hirata, and Rosario Dominguez Crespo Hirata, “Molecular mechanisms underlying statin effects on genes involved in the reverse cholesterol transport,” Drug Metabolism and Drug Interactions, vol. 27, no. 2, pp. 101–111, 2012. View at Publisher · View at Google Scholar
  • E. K. J. Pauwels, and M. H. Bourguignon, “Treatment Of Differentiated Thyroid Cancer: New Players On An Old Field,” Drugs of The Future, vol. 37, no. 2, pp. 119–125, 2012. View at Publisher · View at Google Scholar
  • J. C. Hernandez, J. De la Cruz, and B. Ogayar, “Electrical protection for the grid-interconnection of photovoltaic-distributed generation,” Electric Power Systems Research, vol. 89, pp. 85–99, 2012. View at Publisher · View at Google Scholar
  • Absalon D. Gutierrez, and Ashok Balasubramanyam, “Dysregulation of glucose metabolism in HIV patients: epidemiology, mechanisms, and management,” Endocrine, vol. 41, no. 1, pp. 1–10, 2012. View at Publisher · View at Google Scholar
  • I. Barna, and D. Zelena, “Te biochemical complexity of the endocannabinoid system with some remarks on stress and related disorders: A minireview,” Endocrine Regulations, vol. 46, no. 2, pp. 107–124, 2012. View at Publisher · View at Google Scholar
  • Maria Dalamaga, Kalliope N. Diakopoulos, and Christos S. Mantzoros, “The Role of Adiponectin in Cancer: A Review of Current Evidence,” Endocrine Reviews, vol. 33, no. 4, pp. 547–594, 2012. View at Publisher · View at Google Scholar
  • Maria Cristina De Martino, Peter M. van Koetsveld, Richard A. Feelders, Diana Sprij-Mooij, Marlijn Waaijers, Steven W. J. Lamberts, Wouter W. de Herder, Annamaria Colao, Rosario Pivonello, and Leo J. Hofland, “The role of mTOR inhibitors in the inhibition of growth and cortisol secretion in human adrenocortical carcinoma cells,” Endocrine-Related Cancer, vol. 19, no. 3, pp. 351–364, 2012. View at Publisher · View at Google Scholar
  • Shoba Shetty, Maria A. Ramos-Roman, You-Ree Cho, Jonathan Brown, Jorge Plutzky, Eric S. Muise, Jay D. Horton, Philipp E. Scherer, and Elizabeth J. Parks, “Enhanced fatty acid flux triggered by adiponectin overexpression,” Endocrinology, vol. 153, no. 1, pp. 113–122, 2012. View at Publisher · View at Google Scholar
  • Valentina Gallo, Giovanni Leonardi, Bernd Genser, Maria-Jose Lopez-Espinosa, Stephanie J. Frisbee, Lee Karlsson, Alan M. Ducatman, and Tony Fletcher, “Serum Perfluorooctanoate (PFOA) and Perfluorooctane Sulfonate (PFOS) Concentrations and Liver Function Biomarkers in a Population with Elevated PFOA Exposure,” Environmental Health Perspectives, vol. 120, no. 5, pp. 655–660, 2012. View at Publisher · View at Google Scholar
  • Nikki Gillum Posnack, Luther M. Swift, Matthew W. Kay, Norman H. Lee, and Narine Sarvazyan, “Phthalate Exposure Changes the Metabolic Profile of Cardiac Muscle Cells,” Environmental Health Perspectives, vol. 120, no. 9, pp. 1243–1251, 2012. View at Publisher · View at Google Scholar
  • Gloria B. Post, Perry D. Cohn, and Keith R. Cooper, “Perfluorooctanoic acid (PFOA), an emerging drinking water contaminant: A critical review of recent literature,” Environmental Research, vol. 116, pp. 93–117, 2012. View at Publisher · View at Google Scholar
  • Bing Wu, Su Liu, Xuechao Guo, Yan Zhang, Xuxiang Zhang, Mei Li, and Shupei Cheng, “Responses of Mouse Liver to Dechlorane Plus Exposure by Integrative Transcriptomic and Metabonomic Studies,” Environmental Science & Technology, vol. 46, no. 19, pp. 10758–10764, 2012. View at Publisher · View at Google Scholar
  • Feng Tan, Yihe Jin, Wei Liu, Xie Quan, Jingwen Chen, and Zhen Liang, “Global Liver Proteome Analysis Using iTRAQ Labeling Quantitative Proteomic Technology to Reveal Biomarkers in Mice Exposed to Perfluorooctane Sulfonate (PFOS),” Environmental Science & Technology, vol. 46, no. 21, pp. 12170–12177, 2012. View at Publisher · View at Google Scholar
  • Xin-Mei Zheng, Hong-Ling Liu, Wei Shi, Si Wei, John P. Giesy, and Hong-Xia Yu, “Effects of perfluorinated compounds on development of zebrafish embryos,” Environmental Science and Pollution Research, vol. 19, no. 7, pp. 2498–2505, 2012. View at Publisher · View at Google Scholar
  • Elizabeth R. Gilbert, and Dongmin Liu, “Epigenetics The missing link to understanding beta-cell dysfunction in the pathogenesis of type 2 diabetes,” Epigenetics, vol. 7, no. 8, pp. 841–852, 2012. View at Publisher · View at Google Scholar
  • Razieh Adabi Mohazab, Mehrak Javadi-Paydar, Bahram Delfan, and Ahmad Reza Dehpour, “Possible involvement of PPAR-gamma receptor and nitric oxide pathway in the anticonvulsant effect of acute pioglitazone on pentylenetetrazole-induced seizures in mice,” Epilepsy Research, vol. 101, no. 1-2, pp. 28–35, 2012. View at Publisher · View at Google Scholar
  • Wenwei Hao, Yongping Zhu, Li Meng, Changbao Ni, Jing Yang, and Huifang Zhou, “Serum paraoxonase, arylesterase activity, and oxidative status in patients with nasal polyp,” European Archives of Oto-Rhino-Laryngology, vol. 270, no. 6, pp. 1861–1865, 2012. View at Publisher · View at Google Scholar
  • Pierre Petit, Dominique Hillaire-Buys, Jean-Luc Faillie, and Jean-Louis Montastruc, “Stay vigilant: a glitazone (pioglitazone) can hide a glitazar!,” European Journal of Clinical Pharmacology, vol. 68, no. 12, pp. 1681–1683, 2012. View at Publisher · View at Google Scholar
  • Naglaa Nabil Elmongy, and Olfat Shaker, “Expression of Peroxisome Proliferator Activator Receptor beta/delta (PPAR beta/delta) in acne vulgaris,” European Journal Of Dermatology, vol. 22, no. 1, pp. 42–45, 2012. View at Publisher · View at Google Scholar
  • Jean-Marie Heydel, Philippe Garnier, Philippe Faure, and Yves Artur, “Ciprofibrate regulation of rat hepatic bilirubin glucuronidation and UDP-glucuronosyltransferases expression,” European Journal of Drug Metabolism and Pharmacokinetics, vol. 37, no. 4, pp. 233–240, 2012. View at Publisher · View at Google Scholar
  • Valerio Costa, Marianna Aprile, Roberta Esposito, and Alfredo Ciccodicola, “RNA-Seq and human complex diseases: recent accomplishments and future perspectives,” European Journal of Human Genetics, vol. 21, no. 2, pp. 134–142, 2012. View at Publisher · View at Google Scholar
  • Astrid Schmieder, Kai Schledzewski, Julia Michel, Kathrin Schönhaar, Yannick Morias, Tom Bosschaerts, Jan Van den Bossche, Pierre Dorny, Andrea Sauer, Carsten Sticht, Cyrill Géraud, Zoe Waibler, Alain Beschin, and Sergij Goerdt, “The CD20 homolog Ms4a8a integrates pro- and anti-inflammatory signals in novel M2-like macrophages and is expressed in parasite infection,” European Journal of Immunology, vol. 42, no. 11, pp. 2971–2982, 2012. View at Publisher · View at Google Scholar
  • Stéphane Salamone, Christelle Colin, Isabelle Grillier-Vuissoz, Sandra Kuntz, Sabine Mazerbourg, Stéphane Flament, Hélène Martin, Lysiane Richert, Yves Chapleur, and Michel Boisbrun, “Synthesis of new troglitazone derivatives: Anti-proliferative activity in breast cancer cell lines and preliminary toxicological study,” European Journal of Medicinal Chemistry, vol. 51, pp. 206–215, 2012. View at Publisher · View at Google Scholar
  • Alessandra Ammazzalorso, Alessandra D'Angelo, Antonella Giancristofaro, Barbara De Filippis, Mauro Di Matteo, Marialuigia Fantacuzzi, Letizia Giampietro, Pasquale Linciano, Cristina Maccallini, and Rosa Amoroso, “Fibrate-derived N-(methylsulfonyl)amides with antagonistic properties on PPARα,” European Journal of Medicinal Chemistry, vol. 58, pp. 317–322, 2012. View at Publisher · View at Google Scholar
  • Swapnil Bajare, Jessy Anthony, Amrutha Nair, Rosalind Marita, Anagha Damre, Dharmeshkumar Patel, Chandrika Rao, H. Sivaramakrishnan, and Nabajyoti Deka, “Synthesis of N-(5-chloro-6-(quinolin-3-yloxy)pyridin-3-yl)benzenesulfonamide derivatives as non-TZD peroxisome proliferator-activated receptor γ (PPARγ) agonist,” European Journal of Medicinal Chemistry, vol. 58, pp. 355–360, 2012. View at Publisher · View at Google Scholar
  • V. Hutter, C. Hilgendorf, A. Cooper, V. Zann, D.I. Pritchard, and C. Bosquillon, “Evaluation of layers of the rat airway epithelial cell line RL-65 for permeability screening of inhaled drug candidates,” European Journal of Pharmaceutical Sciences, vol. 47, no. 2, pp. 481–489, 2012. View at Publisher · View at Google Scholar
  • Maria Rosaria Romano, and Marcello Diego Lograno, “Involvement of the peroxisome proliferator-activated receptor (PPAR) alpha in vascular response of endocannabinoids in the bovine ophthalmic artery,” European Journal of Pharmacology, vol. 683, no. 1-3, pp. 197–203, 2012. View at Publisher · View at Google Scholar
  • M. Samah, Abd El-Rahman El-Aidy, Mona K. Tawfik, and Mohamed M.S. Ewais, “Evaluation of the antifibrotic effect of fenofibrate and rosiglitazone on bleomycin-induced pulmonary fibrosis in rats,” European Journal of Pharmacology, vol. 689, no. 1-3, pp. 186–193, 2012. View at Publisher · View at Google Scholar
  • Chen Qu, Susan W.S. Leung, Paul M. Vanhoutte, and Ricky Y.K. Man, “Wy14643 improves vascular function in the aorta of the spontaneously hypertensive rat mainly by activating peroxisome proliferator-activated receptors alpha,” European Journal of Pharmacology, vol. 696, no. 1-3, pp. 101–110, 2012. View at Publisher · View at Google Scholar
  • Gong Yong Jin, Se Mi Bok, Young Min Han, Myung Ja Chung, Kwon-Ha Yoon, So Ri Kim, and Yong Chul Lee, “Effectiveness of rosiglitazone on bleomycin-induced lung fibrosis: Assessed by micro-computed tomography and pathologic scores,” European Journal of Radiology, vol. 81, no. 8, pp. 1901–1906, 2012. View at Publisher · View at Google Scholar
  • So-Young Lee, So-Lim Park, Jin-Taek Hwang, Sung-Hun Yi, Young-Do Nam, and Seong-Il Lim, “Antidiabetic Effect of Morinda citrifolia (Noni) Fermented by Cheonggukjang in KK-Ay Diabetic Mice,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, pp. 1–8, 2012. View at Publisher · View at Google Scholar
  • M. K. Song, B. D. Roufogalis, and T. H. W. Huang, “Reversal of the Caspase-Dependent Apoptotic Cytotoxicity Pathway by Taurine from Lycium barbarum (Goji Berry) in Human Retinal Pigment Epithelial Cells: Potential Benefit in Diabetic Retinopathy,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, pp. 1–11, 2012. View at Publisher · View at Google Scholar
  • Xiaobo Ding, Shengjie Fan, Yan Lu, Yu Zhang, Ming Gu, Lu Zhang, Gaigai Liu, Lu Guo, Dong Jiang, Xiong Lu, Yiming Li, Zhiqin Zhou, and Cheng Huang, “Citrus ichangensis Peel Extract Exhibits Anti-Metabolic Disorder Effects by the Inhibition of PPAR and LXR Signaling in High-Fat Diet-Induced C57BL/6 Mouse,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, pp. 1–10, 2012. View at Publisher · View at Google Scholar
  • Jennifer C. Carter, and Frank C. Church, “Mature breast adipocytes promote breast cancer cell motility,” Experimental and Molecular Pathology, vol. 92, no. 3, pp. 312–317, 2012. View at Publisher · View at Google Scholar
  • Hayato Maeda, Mao Yamazaki, and Yohtaro Katagata, “Kuromoji (Lindera umbellata) essential oil-induced apoptosis and differentiation in human leukemia HL-60 cells,” Experimental And Therapeutic Medicine, vol. 3, no. 1, pp. 49–52, 2012. View at Publisher · View at Google Scholar
  • Shizuko Nagao, Masanori Kugita, Daisuke Yoshihara, and Tamio Yamaguchi, “Animal models for human polycystic kidney disease,” Experimental Animals, vol. 61, no. 5, pp. 477–488, 2012. View at Publisher · View at Google Scholar
  • John D. Imig, Katie A. Walsh, Md Abdul Hye Khan, Tasuku Nagasawa, Mary Cherian-Shaw, Sean M. Shaw, and Bruce D. Hammock, “Soluble epoxide hydrolase inhibition and peroxisome proliferator activated receptor γ agonist improve vascular function and decrease renal injury in hypertensive obese rats,” Experimental Biology and Medicine, vol. 237, no. 12, pp. 1402–1412, 2012. View at Publisher · View at Google Scholar
  • Shunro Kawaminami, Steven Breakspear, Yumiko Saga, Bernd Noecker, Yoshinori Masukawa, Masaru Tsuchiya, Masashi Oguri, Yosuke Inoue, Kazutaka Ishikawa, and Masayuki Okamoto, “ Deletion of the Sox21 gene drastically affects hair lipids ,” Experimental Dermatology, vol. 21, no. 12, pp. 974–976, 2012. View at Publisher · View at Google Scholar
  • Stefania Briganti, Enrica Flori, Arianna Mastrofrancesco, Daniela Kovacs, Emanuela Camera, Matteo Ludovici, Giorgia Cardinali, and Mauro Picardo, “Azelaic acid reduced senescence-like phenotype in photo-irradiated human dermal fibroblasts: possible implication of PPARγ,” Experimental Dermatology, vol. 22, no. 1, pp. 41–47, 2012. View at Publisher · View at Google Scholar
  • Shyang-Rong Shih, Wei-Yih Chiu, Tien-Chun Chang, and Chin-Hsiao Tseng, “Diabetes and Thyroid Cancer Risk: Literature Review,” Experimental Diabetes Research, vol. 2012, pp. 1–7, 2012. View at Publisher · View at Google Scholar
  • Biagio Arcidiacono, Stefania Iiritano, Aurora Nocera, Katiuscia Possidente, Maria T. Nevolo, Valeria Ventura, Daniela Foti, Eusebio Chiefari, and Antonio Brunetti, “Insulin Resistance and Cancer Risk: An Overview of the Pathogenetic Mechanisms,” Experimental Diabetes Research, vol. 2012, pp. 1–12, 2012. View at Publisher · View at Google Scholar
  • Christina Lamers, Manfred Schubert-Zsilavecz, and Daniel Merk, “Therapeutic modulators of peroxisome proliferator-activated receptors (PPAR): a patent review (2008–present),” Expert Opinion on Therapeutic Patents, vol. 22, no. 7, pp. 803–841, 2012. View at Publisher · View at Google Scholar
  • Kenji Matsumoto, and Shin-ichiro Yokoyama, “Induction of uncoupling protein-1 and -3 in brown adipose tissue by kaki-tannin in type 2 diabetic NSY/Hos mice,” Food and Chemical Toxicology, vol. 50, no. 2, pp. 184–190, 2012. View at Publisher · View at Google Scholar
  • Diana M. Cheng, Peter Kuhn, Alexander Poulev, Leonel E. Rojo, Mary Ann Lila, and Ilya Raskin, “In vivo and in vitro antidiabetic effects of aqueous cinnamon extract and cinnamon polyphenol-enhanced food matrix,” Food Chemistry, vol. 135, no. 4, pp. 2994–3002, 2012. View at Publisher · View at Google Scholar
  • Tao Chen, Xiaoping Jin, Brian H. Crawford, Hua Cheng, Talib B. Saafir, Mary B. Wagner, Zuyi Yuan, and Guoliang Ding, “Cardioprotection from oxidative stress in the newborn heart by activation of PPARγ is mediated by catalase,” Free Radical Biology and Medicine, vol. 53, no. 2, pp. 208–215, 2012. View at Publisher · View at Google Scholar
  • Ana M. Ferreira, Lucia Minarrieta, Maria Lamas Bervejillo, and Homero Rubbo, “Nitro-fatty acids as novel electrophilic ligands for peroxisome proliferator-activated receptors,” Free Radical Biology And Medicine, vol. 53, no. 9, pp. 1654–1663, 2012. View at Publisher · View at Google Scholar
  • Lynn Ulatowski, Cara Dreussi, Noa Noy, Jill Barnholtz-Sloan, Eric Klein, and Danny Manor, “Expression of the α-tocopherol transfer protein gene is regulated by oxidative stress and common single-nucleotide polymorphisms,” Free Radical Biology and Medicine, vol. 53, no. 12, pp. 2318–2326, 2012. View at Publisher · View at Google Scholar
  • Wei Li, Qingyong Ma, Jiangbo Liu, Liang Han, Guodong Ma, Han Liu, Tao Shan, Keping Xie, and Erxi Wu, “Hyperglycemia as a mechanism of pancreatic cancer metastasis,” Frontiers in Bioscience, vol. 17, no. 5, pp. 1761–1774, 2012. View at Publisher · View at Google Scholar
  • Gregory T. Robbins, and Daotai Nie, “PPAR gamma, bioactive lipids, and cancer progression,” Frontiers in Bioscience-Landmark, vol. 17, pp. 1816–1834, 2012. View at Publisher · View at Google Scholar
  • Xue Cai, and James F. McGinnis, “Oxidative stress: The achilles' heel of neurodegenerative diseases of the retina,” Frontiers In Bioscience-Landmark, vol. 17, pp. 1976–1995, 2012. View at Publisher · View at Google Scholar
  • Dung V. Nguyen, Lynn C. Shaw, and Maria B. Grant, “Inflammation in the pathogenesis of microvascular complications in diabetes,” Frontiers in Endocrinology, vol. 3, 2012. View at Publisher · View at Google Scholar
  • Andrzej Bartke, and Reyhan Westbrook, “Metabolic characteristics of long-lived mice,” Frontiers in Genetics, vol. 3, pp. 1–6, 2012. View at Publisher · View at Google Scholar
  • Sudin Bhattacharya, Paul B. Watkins, Melvin E. Andersen, Lisl K.M. Shoda, Qiang Zhang, Courtney G. Woods, Brett A. Howell, Scott Q. Siler, Jeffrey L. Woodhead, Yuching Yang, and Patrick McMullen, “Modeling drug-and chemical-induced hepatotoxicity with systems biology approaches,” Frontiers in Neurology, vol. 3, 2012. View at Publisher · View at Google Scholar
  • James Ming Phang, Wei Liu, Chad Hancock, and Kyle J Christian, “The proline regulatory axis and cancer.,” Frontiers in oncology, vol. 2, pp. 60, 2012. View at Publisher · View at Google Scholar
  • Dana Greene-Schloesser, Mike E Robbins, Ann M Peiffer, Edward G Shaw, Kenneth T Wheeler, and Michael D Chan, “Radiation-induced brain injury: A review.,” Frontiers in oncology, vol. 2, pp. 73, 2012. View at Publisher · View at Google Scholar
  • Adam Beach, Michelle T. Bursteinf, Vincent R. Richard, Anna Leonov, Sean Levy, and Vladimir I. Titorenko, “Integration of peroxisomes into an endomembrane system that governs cellular aging,” Frontiers in Physiology, vol. 3, pp. 1–11, 2012. View at Publisher · View at Google Scholar
  • João M Carvas, Jean-Pierre Montani, Zhihong Yang, Ana Vukolic, Gautham Yepuri, Yuyan Xiong, Katja Popp, Isabelle Schmutz, Sylvie Chappuis, Urs Albrecht, and Xiu-Fen Ming, “Period2 gene mutant mice show compromised insulin-mediated endothelial nitric oxide release and altered glucose homeostasis.,” Frontiers in physiology, vol. 3, pp. 337, 2012. View at Publisher · View at Google Scholar
  • Sara L Dunn, J Mark Wilkinson, Aileen Crawford, Christine L Le Maitre, and Rowena AD Bunning, “Cannabinoids: novel therapies for arthritis?,” Future Medicinal Chemistry, vol. 4, no. 6, pp. 713–725, 2012. View at Publisher · View at Google Scholar